Testicular nonseminoma (NSGCT)

Also called Testicular nonseminomatous germ cell tumor

Testicular nonseminomatous germ-cell tumors include several histologies, such as embryonal carcinoma, yolk-sac tumor, choriocarcinoma and teratoma, often in mixed tumors. Stage, tumor markers and the specific components guide treatment.

Other names and abbreviations

NSGCT, nonseminoma, testicular nonseminomatous germ cell tumor, testicular germ cell cancer, embryonal carcinoma, yolk sac tumor, choriocarcinoma, mixed germ cell tumor, Nonseminomatous germ cell tumour of the testis, mixed germ cell tumour when mixed histologies are present

In short

  • Testicular nonseminomas are germ cell cancers of the testicle, often made of mixed tumor types, that mainly affect teens and younger adult men.
  • Treatment starts with surgery on the testicle, then may mean close follow-up, platinum-based chemotherapy or more surgery, depending on risk.
  • For some cancers that come back or do not respond, high-dose chemotherapy with a return of the patient's own stem cells is an established option, and no donor is normally needed.
Jump to a section

Underlined words open a short explanation. See all terms

Where transplant fits

with is an established option in selected or germ-cell tumor settings. The patient’s own cells restore blood production after chemotherapy. A registry donor is not normally needed, and is not routine for every newly diagnosed testicular cancer.

Treatment depends on the exact diagnosis, disease stage, prior treatment and the person’s health.

Key facts

Who it affects
These tumors mainly affect adolescents and younger adult males.
Usual treatment
Treatment begins with testicular surgery and may involve surveillance, platinum-based chemotherapy or further surgery according to risk. Relapsed disease can be treated with conventional-dose salvage chemotherapy or a high-dose approach in an expert center.
Cells used in a transplant
The patient’s own collected blood-forming cells for autologous stem cell rescue, when that procedure is appropriate.
Where a donor fits
Limited transplant role

Support for patients and families

These independent organizations offer information and support. JBF is not affiliated with them.

Questions to bring to your care team

  • What is the exact name of the diagnosis or subtype, and what does it mean for treatment?
  • What is the goal of each treatment you are suggesting?
  • What would make a transplant worth considering later on?
  • Are there clinical trials that might fit?
  • Where can our family find support during treatment?

Supporting someone with a diagnosis

Sources and further reading

  1. Testicular Cancer Treatment (PDQ)
    NCI, Accessed 2026-09-05
  2. Indications for haematopoietic cell transplantation and CAR-T: 2025 EBMT practice recommendations
    EBMT / Bone Marrow Transplantation, Accessed 2026-09-05
  3. Stem Cell and Bone Marrow Transplants for Cancer
    NCI, Accessed 2026-09-05

Other patients are waiting for a match.

Most people with testicular nonseminoma (NSGCT) are treated without a registry donor. Many people with other blood cancers and blood disorders need a donor who is a stranger.

Join the registry

JBF points you to the official registry that serves your country. It explains who can join and what donation involves.

Help a family run a drive

If someone you love needs a donor, a registration drive can add many potential donors at once, for them and for others.

Support this work

Gifts to the Jada Bascom Foundation support donor-awareness education like this guide, community outreach, drive planning and referrals to official registries.

Donate to JBF

We respect your privacy. Unsubscribe anytime.

Keep learning